New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For MDT;CRDC;GE;SYK;AET From The Last 14 Days
Check below for free stories on MDT;CRDC;GE;SYK;AET the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
April 23, 2014
14:36 EDTAETEarnings Preview: Aetna shares relatively flat since last earnings report
Aetna (AET) is scheduled to report first quarter earnings before the market open on Thursday, April 24 with a conference call scheduled for 8:30 am ET. Aetna operates as a diversified health care benefits company in the United States. EXPECTATIONS: Analysts are looking for earnings per share of $1.56 on revenue of $13.72B, according to First Call. The consensus range for EPS is $1.44-$1.63 on revenue of $13.31B-$14.28B. LAST QUARTER:On February 6, Aetna reported fourth quarter EPS of $1.34 against estimates of $1.36 on revenue of $13.1B against estimates of $13.14B. In its Q4 report, Aetna said it sees medical membership rising by 50,000 at end of Q1. On April 17, Aetna and other health insurers fell after UnitedHealth (UNH) reported lower than expected Q1 revenue and cited taxes levied by the Affordable Care Act and weak funding of Medicare Advantage by the government weighed on results. STREET RESEARCH: On March 25, FBR Capital removed Aetna from its Top Picks List due to share performance. PRICE ACTION: Shares of Aetna are up approximately 1.5% to $68.99 since its last earnings report. Shares are fractionally higher today in afternoon trading.
08:30 EDTGEPDF Solutions sell-off creates long-term opportunity, says DA Davidson
Subscribe for More Information
08:06 EDTGEGE Capital leads $135M in credit facilities for King's Hawaiian
Subscribe for More Information
07:00 EDTAETTerrapinn to hold a conference
Subscribe for More Information
April 22, 2014
10:04 EDTMDTMedtronic announces first U.S. implant of Evera MRI SureScan
Subscribe for More Information
07:25 EDTGENatural E Creative Group to hold a summit
Subscribe for More Information
April 21, 2014
18:47 EDTMDTInjunction delay 'temporary victory' for Medtronic, says Wells Fargo
Subscribe for More Information
18:20 EDTMDTEdwards Lifesciences comments on U.S. Appeals Court order
Edwards Lifesciences (EW) announced that the U.S. Court of Appeals for the Federal Circuit issued a stay for the preliminary injunction that was ordered on April 11 to limit the sale of Medtronic's (MDT) CoreValve system in the United States. According to the court's two-to-one decision, the injunction has been placed on hold "pending further notice." "We have always made every effort to ensure patients receive the treatment they need and will continue to seek a durable solution that benefits physicians and their patients. We're proud of the track record and large amount of clinical data supporting the performance of the SAPIEN family of valves, making them the preferred choice for doctors treating their patients around the world," said Michael A. Mussallem, Edwards' chairman and CEO. The order postpones the implementation of the preliminary injunction. It does not reverse the federal jury's finding of Medtronic's willful infringement, for which all appeals have been exhausted, and does not affect the determination of additional damages.
16:40 EDTMDTMedtronic confirms stay in case with Edwards regarding CoreValve granted
Subscribe for More Information
15:55 EDTMDTMedtronic motion for stay in case with Edwards granted, Bloomberg reports
Subscribe for More Information
15:42 EDTMDTLeerink's medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy discusses the litigation landscape and the next steps and potential outcomes for Edwards Lifesciences and Medtronic on an Analyst/Industry conference call to be held on April 23 at 2 pm.
09:09 EDTMDTMedtronic reports court to expedite appeal in Edwards Lifesciences case
Subscribe for More Information
08:04 EDTGEGE unit is agent on $66M credit facility for Gold Star Foods acquisition
Subscribe for More Information
07:21 EDTMDTFDA Pediatric Advisory Committee to hold a meeting
The Committee discusses pediatric-focused safety reviews including MDT's Activa Dystonia Therapy, (BAX's Advate and Tisseel, NVS' Famvir, Tibotec's (JNJ subsidiary) Intelence, UCB Pharma's Keppra, MRK's Maxalt, BAYRY's Natazia, Digestive Care's Pertzye, JNJ's Prezista, BMY's Reyataz, SNY's Sklice, PFE's Torisel, Aptalis' Ultresa, and GILD's Viread in a meeting being held in Bethesda, Maryland on April 21 at 8 am. Webcast Link
April 17, 2014
12:53 EDTAET, GEOn The Fly: Midday Wrap
Subscribe for More Information
10:51 EDTAETHealth insurers slide after UnitedHealth results, cautious comments
Shares of a number of health insurers are falling after the largest company in the sector, UnitedHealth (UNH), reported slightly higher than expected first quarter profit but lower than expected revenue. WHAT'S NEW: UnitedHealth's first quarter earnings per share came in at $1.10, versus the consensus outlook of $1.09. The insurer reported revenue of $31.71B, compared with the consensus outlook of $31.99B. Taxes levied by the Affordable Care Act and weak funding of Medicare Advantage by the government weighed on UnitedHealth's earnings, the company stated. Also pushing down the company's earnings was "a very expensive," new Hepatitis C therapy, UnitedHealth stated on its earnings conference call. Hepatitis C treatments cost UnitedHealth hundreds of millions of dollars in the first quarter, the company stated, though it also noted that demand for the treatments should drop going forward as initial pent-up demand for them starts to decline. The company indicated that it was looking to be reimbursed by states for the money it is spending on hepatitis vaccines for Medicaid patients. Meanwhile, UnitedHealth reiterated its fiscal 2014 EPS guidance of $5.40-$5.60 and its fiscal 2014 revenue guidance of $128B-$129B. PRICE ACTION: In mid-morning trading, UnitedHealth sank 3.7% to $75.31. Other health insurers also declined, with WellPoint (WLP) dropping 4% to $91.89, Aetna (AET) falling 3.3% to $67.54, Humana (HUM) declining 2.25% to $106.35, and Health Net (HNT) sliding 1% to $31.74.
09:07 EDTGEGE Capital says sees Q2 run rate of about $1.8B of earnings
09:05 EDTGEGeneral Electric says saw some improvement in credit demand in Q1
Subscribe for More Information
08:17 EDTGEGeneral Electric says focusing on bolt-on acquisitions
Says on track to reduce share count in 2014 and planning for 9-9.5B by 2015. Says continuing to grow dividends in line with earnings. Says M&A focused on building out core: Focusing on bolt-on acquisitions, active on divestiture front, go above $1B-$4B range only for "exceptional" value and immediate accretion. Says oil and gas industry fundamentals remain strong. Says U.S. short-cycle markets strengthened in March, appears that weather impact a "one-time" event. Says had a few "rough spots" in Q1: U.S. Healthcare and Transportation/mining. Comments from slides that will be presented on the Q1 earnings conference call.
06:35 EDTGEGeneral Electric on track to achieve goal of $1B in structural cost-out for year
Subscribe for More Information
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use